These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
377 related items for PubMed ID: 11326821
1. Association between tuberculosis and HIV disease progression in a high tuberculosis prevalence area. Badri M, Ehrlich R, Wood R, Pulerwitz T, Maartens G. Int J Tuberc Lung Dis; 2001 Mar; 5(3):225-32. PubMed ID: 11326821 [Abstract] [Full Text] [Related]
2. Impact of tuberculosis on the course of HIV-infected patients with a high initial CD4 lymphocyte count. Mañas E, Pulido F, Peña JM, Rubio R, Gonzalez-García J, Costa R, Pérez-Rodríguez E, Del Palacio A. Int J Tuberc Lung Dis; 2004 Apr; 8(4):451-7. PubMed ID: 15141738 [Abstract] [Full Text] [Related]
3. Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings. Bedell R, Heath KV, Hogg RS, Wood E, Press N, Yip B, O'Shaughnessy MV, Montaner JS. Antivir Ther; 2003 Oct; 8(5):379-84. PubMed ID: 14640384 [Abstract] [Full Text] [Related]
5. HIV-associated extrapulmonary tuberculosis in Thailand: epidemiology and risk factors for death. Kingkaew N, Sangtong B, Amnuaiphon W, Jongpaibulpatana J, Mankatittham W, Akksilp S, Sirinak C, Nateniyom S, Burapat C, Kittikraisak W, Monkongdee P, Varma JK. Int J Infect Dis; 2009 Nov; 13(6):722-9. PubMed ID: 19196530 [Abstract] [Full Text] [Related]
6. HIV-1 co-infection in children hospitalised with tuberculosis in South Africa. Madhi SA, Huebner RE, Doedens L, Aduc T, Wesley D, Cooper PA. Int J Tuberc Lung Dis; 2000 May; 4(5):448-54. PubMed ID: 10815739 [Abstract] [Full Text] [Related]
7. Risk factors for active tuberculosis after antiretroviral treatment initiation in Abidjan. Seyler C, Toure S, Messou E, Bonard D, Gabillard D, Anglaret X. Am J Respir Crit Care Med; 2005 Jul 01; 172(1):123-7. PubMed ID: 15805184 [Abstract] [Full Text] [Related]
8. The V118I mutation as a marker of advanced HIV infection and disease progression. Zaccarelli M, Tozzi V, Lorenzini P, Forbici F, Narciso P, Ceccherini-Silberstein F, Trotta MP, Bertoli A, Liuzzi G, Marconi P, Mosti S, Perno CF, Antinori A. Antivir Ther; 2007 Jul 01; 12(2):163-8. PubMed ID: 17503658 [Abstract] [Full Text] [Related]
9. Incidence of tuberculosis in HIV-infected patients receiving HAART: interaction between TST and CD4 count. Martín-Echevarria E, Rodríguez-Zapata M, Torralba M, Fernández JM, Moreno A, Casado JL, Dronda F, Pérez-Elías MJ, Navas E, Moreno S. Int J Tuberc Lung Dis; 2011 Oct 01; 15(10):1347-52. PubMed ID: 22283893 [Abstract] [Full Text] [Related]
10. Pregnancy and HIV disease progression during the era of highly active antiretroviral therapy. Tai JH, Udoji MA, Barkanic G, Byrne DW, Rebeiro PF, Byram BR, Kheshti A, Carter JD, Graves CR, Raffanti SP, Sterling TR. J Infect Dis; 2007 Oct 01; 196(7):1044-52. PubMed ID: 17763327 [Abstract] [Full Text] [Related]
11. Predictors of clinical progression among HIV-1-positive patients starting HAART with CD4+ T-cell counts > or =200 cells/mm3. Lapadula G, Torti C, Maggiolo F, Casari S, Suter F, Minoli L, Pezzoli C, Di Pietro M, Migliorino G, Ouiros-Roldan E, Ladisa N, Sighinolfi L, Costarelli S, Carosi G, Italian MASTER Cohort. Antivir Ther; 2007 Oct 01; 12(6):941-7. PubMed ID: 17926648 [Abstract] [Full Text] [Related]
16. Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy. Sullivan PS, Hanson DL, Teshale EH, Wotring LL, Brooks JT. AIDS; 2006 May 12; 20(8):1171-9. PubMed ID: 16691069 [Abstract] [Full Text] [Related]
17. Hepatitis C virus coinfection and HIV load, CD4+ cell percentage, and clinical progression to AIDS or death among HIV-infected women: Women and Infants Transmission Study. Hershow RC, O'Driscoll PT, Handelsman E, Pitt J, Hillyer G, Serchuck L, Lu M, Chen KT, Yawetz S, Pacheco S, Davenny K, Adeniyi-Jones S, Thomas DL. Clin Infect Dis; 2005 Mar 15; 40(6):859-67. PubMed ID: 15736020 [Abstract] [Full Text] [Related]
18. Survival in a cohort of human immunodeficiency virus-infected tuberculosis patients in New York City. Implications for the expansion of the AIDS case definition. Stoneburner R, Laroche E, Prevots R, Singh T, Blum S, Terry P, Reatrice S, Adler J. Arch Intern Med; 1992 Oct 15; 152(10):2033-7. PubMed ID: 1358042 [Abstract] [Full Text] [Related]
19. Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy. Rockstroh JK, Mocroft A, Soriano V, Tural C, Losso MH, Horban A, Kirk O, Phillips A, Ledergerber B, Lundgren J, EuroSIDA Study Group. J Infect Dis; 2005 Sep 15; 192(6):992-1002. PubMed ID: 16107951 [Abstract] [Full Text] [Related]
20. Clinical experience of the 23-valent capsular polysaccharide pneumococcal vaccination in HIV-1-infected patients receiving highly active antiretroviral therapy: a prospective observational study. Hung CC, Chen MY, Hsieh SM, Hsiao CF, Sheng WH, Chang SC. Vaccine; 2004 May 07; 22(15-16):2006-12. PubMed ID: 15121313 [Abstract] [Full Text] [Related] Page: [Next] [New Search]